Lixisenatide attenuates advanced glycation end products (AGEs)-induced degradation of extracellular matrix in human primary chondrocytes
Volume 47, Issue 1, December 2019, Page 1256-1264 .
Source: Artificial Cells, Blood Substitutes, and Biotechnology - Category: Biotechnology Authors: Xin Li Fangteng Jia Zhengqing Zhu Lanfeng Huang Source Type: research
More News: Biotechnology